关于德拉弗洛克萨辛临床相关性质的最新评论
Adrien Turban1, François Guérin1,2, Aurélien Dinh3
1Department of Bacteriology, University Hospital of Rennes, 2 Rue Henri Le Guilloux, 35000 Rennes, France.
Antibiotics (Basel, Switzerland)
|August 26, 2023
概括
德拉弗洛克萨是一种新的诺基诺,对抗性格拉姆阳性细菌表现出强烈的活性,对皮肤感染和肺炎有效. 它的独特特性使其成为一个有前途的新型抗生素选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 诺基诺的广泛使用导致了显著的细菌耐药性.
- 对于新型抗微生物化合物来对抗耐药性感染有着至关重要的需求.
研究的目的:
- 评估delafloxacin的疗效和安全性,一个新的诺基诺,用于治疗细菌感染.
- 要突出delafloxacin的独特特性,包括在酸性条件下的活性和广泛的疗效.
主要方法:
- 进行了临床试验 (第二阶段和第三阶段),以比较delafloxacin与标准护理疗法.
- 在体外研究中评估了delafloxacin对格拉姆阳性细菌的活性,以及其对II型拓酶的亲和力.
主要成果:
- 德拉弗洛克萨辛证明与皮肤感染和社区获得的细菌性肺炎的标准治疗方法无劣.
- 该药物在体外对包括耐药菌株在内的GRAM阳性细菌表现出高的活性.
- 德拉弗洛克萨辛对DNA旋转酶和IV型拓聚酶表现出相当的亲和力.
结论:
- 德拉弗洛克萨是针对特定细菌感染的有效和耐受良好的治疗选择.
- 其广泛的活性和有利的特性将其定位为对抗细菌感染的有希望的分子,特别是那些具有诺基诺抗性的细菌感染.
关键词:
这就是ABSSSI ABSSSI的意思.在CAP CAP中,我们可以把它转换为CAP.诺基诺的化.这种药物是levofloxacin.莫西弗洛克萨辛 (moxifloxacin) 是一种药物.电阻的阻力可以这种类型的 topoisomeraseses.更多相关视频
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.7K
07:28Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
8.7K
相关概念视频
01:28Antimicrobial Effectiveness
48
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
48
01:19Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353